Abstract:Background Challenges persist in achieving automatic and efficient inflammation quantification using dynamic contrast‐enhanced (DCE) MRI in rheumatoid arthritis (RA) patients. Purpose To investigate an automatic artificial intelligence (AI) approach and an optimized dynamic MRI protocol for quantifying disease activity in RA in whole hands while excluding arterial pixels. Study Type Retrospective. Subjects Twelve RA patients underwent DCE‐MRI with 27 phases for creating the AI model and tested on images with a variable number of phases from 35 RA patients. Field Strength/Sequence 3.0 T/DCE T1‐weighted gradient echo sequence (mDixon, water image). Assessment The model was trained with various DCE‐MRI time‐intensity number of phases. Evaluations were conducted for similarity between AI segmentation and manual outlining in 51 ROIs with synovitis. The relationship between synovial volume via AI segmentation with rheumatoid arthritis magnetic resonance imaging scoring (RAMRIS) across whole hands was then evaluated. The reference standard was determined by an experienced musculoskeletal radiologist. Statistical Test Area under the curve (AUC) of receiver operating characteristic (ROC), Dice and Spearman's rank correlation coefficients, and interclass correlation coefficient (ICC). A P‐value <0.05 was considered statistically significant. Results A minimum of 15 phases (acquisition time at least 2.5 minutes) was found to be necessary. AUC ranged from 0.941 ± 0.009 to 0.965 ± 0.009. The Dice score was 0.557–0.615. Spearman's correlation coefficients between the AI model and ground truth were 0.884–0.927 and 0.736–0.831, for joint ROIs and whole hands, respectively. The Spearman's correlation coefficient for the additional test set between the model trained with 15 phases and RAMRIS was 0.768. Conclusion The AI‐based classification model effectively identified synovitis pixels while excluding arteries. The optimal performance was achieved with at least 15 phases, providing a quantitative assessment of inflammatory activity in RA while minimizing acquisition time. Evidence Level 3 Technical Efficacy Stage 2

Predict Rheumatoid Arthritis Conversion from Undifferentiated Arthritis with Dynamic Contrast-Enhanced MRI and Laboratory Indexes.

Diagnosis and Application of Combine Detection on Pyridine Cross-linked Comprehensive Peptide of Type Ⅰ Collagen,Matrix Metalloproteinase Enzyme-3 Projects,CCP and RF in Patients with Early Rheumatoid Arthritis

The value of pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen (ICTP) in early rheumatoid arthritis(RA)

Clinical utility of anti-citrullinated peptide antibodies in patients with rheumatoid arthritis

Early Prediction of Rheumatoid Arthritis by Magnetic Resonance Imaging in the Absence of Anti-Cyclic Citrullinated Peptide Antibodies and Radiographic Erosions in Undifferentiated Inflammatory Arthritis Patients: A Prospective Study

Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies

Clinical Markers Combined with HMGB1 Polymorphisms to Predict Efficacy of Conventional DMARDs in Rheumatoid Arthritis Patients.

Identification of novel urinary biomarkers for assessing disease activity and prognosis of rheumatoid arthritis

Comparison of the clinical effectiveness of US grading scoring system vs MRI in the diagnosis of early rheumatoid arthritis (RA)

The value of quantitative evaluation of inlfammatory activity by using wrist dynamic contrast-enhanced MRI in rheumatoid arthritis

The Combination of 18F-Fluorodeoxyglucose Positron Emission Tomography Metabolic and Clinical Parameters Can Effectively Distinguish Rheumatoid Arthritis and Polymyalgia Rheumatic

Combination of scavenger receptor-A with anti-cyclic citrullinated peptide antibody for the diagnosis of rheumatoid arthritis

The Additional Benefit of Ultrasonography to 2010 ACR/EULAR Classification Criteria when Diagnosing Rheumatoid Arthritis in the Absence of Anti-Cyclic Citrullinated Peptide Antibodies

Value of Serum Collagen Triple Helix Repeat Containing-1(Cthrc1) and 14-3-3η Protein Compared to Anti-Ccp Antibodies and Anti-Mcv Antibodies in the Diagnosis of Rheumatoid Arthritis

Raman Spectroscopy As a Promising Diagnostic Method for Rheumatoid Arthritis.

[Predictive Values of Anti-Cyclic Citrullinated Peptide Antibody, Antikeratin Antibody and Rheumatoid Factor in Diagnosing Articular Erosions in Patients with Rheumatoid Arthritis].

Prediction of Future Rheumatoid Arthritis in Chinese Patients with Early Arthritis: an Effective Way of Patient Care

Predictive Value of Anti-Mutated Citrullinated Vimentin Antibody on One-Year Radiographic Progression in Patients with Rheumatoid Arthritis

Machine Learning-Enhanced Clinical and Ultrasound Technology for Early Detection of Difficult-to-treat Rheumatoid Arthritis

[Evaluation of MRI in the Diagnosis of Rheumatoid Arthritis].

Artificial Intelligence Quantification of Enhanced Synovium Throughout the Entire Hand in Rheumatoid Arthritis on Dynamic Contrast‐Enhanced MRI